Patents by Inventor Andrew Bloecher

Andrew Bloecher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIES
    Publication number: 20220401442
    Abstract: The present disclosure relates, in general, to therapeutic combinations of acalabrutinib and capivasertib, and to corresponding methods of treatment, pharmaceutical compositions, and kits.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 22, 2022
    Applicant: AstraZeneca AB
    Inventors: Hannah DRY, Brandon WILLIS, Andrew BLOECHER, Jerome METTETAL
  • COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN AKT INHIBITOR
    Publication number: 20130287763
    Abstract: The present invention relates to a method of treating cancer by administering an IGF-1R specific antibody in combination with an anti-cancer agent exemplified by an Akt pathway inhibitor. The first and second amounts together comprise a therapeutically effective amount.
    Type: Application
    Filed: July 25, 2011
    Publication date: October 31, 2013
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Sriram Sathyanarayanan, Christopher Winter, Andrew Bloecher, Erin Valentine